MicroRNA-18a-5p Suppresses Tumor Growth via Targeting Matrix Metalloproteinase-3 in Cisplatin-Resistant Ovarian Cancer is a research paper published in Frontiers in Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Minority Health and Health Disparities
Grant: U54 MD007600 , R25-GM061838
NIGMS NIH HHS
Grant: R25 GM061838
NIMHD NIH HHS
Grant: U54 MD007600
National Institutes of Health
Grant: 2U54MD007600-31
Center for Colaborative Research in Minority Health and Health Disparities
National Institutes of Health
Grant: 5R25GM061838-22
NIGMS RISE Program at the UPR Medical Sciences Campus
FWCI
1.41
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance
Additional file 2 of miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance
Additional file 2 of miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance
Additional file 1 of miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance